Concomitant Sjögren’s Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis

Table 5

UK-PBC risk scores.

	PBC(N=226)	PBC/SS(N=56)	P value
5 years	0.054(0.027,0.175)	0.053(0.021,0.137)	0.709
10 years	0.171(0.088,0.474)	0.167(0.067,0.389)	0.710
15 years	0.295(0.158,0.698)	0.289(0.121,0.600)	0.707

Data are expressed as the median (interquartile range).